{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35304580",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "03",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "242",
      "10.1038/s42003-022-03189-z"
    ],
    "Journal": {
      "ISSN": "2399-3642",
      "JournalIssue": {
        "Volume": "5",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "18"
        }
      },
      "Title": "Communications biology",
      "ISOAbbreviation": "Commun Biol"
    },
    "ArticleTitle": "Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.",
    "Pagination": {
      "StartPage": "242",
      "MedlinePgn": "242"
    },
    "Abstract": {
      "AbstractText": [
        "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are limited therapeutic options for the prevention and treatment of SARS-CoV-2 infections. We evaluated the antiviral activity of sulforaphane (SFN), the principal biologically active phytochemical derived from glucoraphanin, the naturally occurring precursor present in high concentrations in cruciferous vegetables. SFN inhibited in vitro replication of six strains of SARS-CoV-2, including Delta and Omicron, as well as that of the seasonal coronavirus HCoV-OC43. Further, SFN and remdesivir interacted synergistically to inhibit coronavirus infection in vitro. Prophylactic administration of SFN to K18-hACE2 mice prior to intranasal SARS-CoV-2 infection significantly decreased the viral load in the lungs and upper respiratory tract and reduced lung injury and pulmonary pathology compared to untreated infected mice. SFN treatment diminished immune cell activation in the lungs, including significantly lower recruitment of myeloid cells and a reduction in T cell activation and cytokine production. Our results suggest that SFN should be explored as a potential agent for the prevention or treatment of coronavirus infections."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-8571-0655"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu."
          }
        ],
        "LastName": "Ordonez",
        "ForeName": "Alvaro A",
        "Initials": "AA"
      },
      {
        "Identifier": [
          "0000-0002-7290-8646"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Bullen",
        "ForeName": "C Korin",
        "Initials": "CK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pulmonology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Villabona-Rueda",
        "ForeName": "Andres F",
        "Initials": "AF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Thompson",
        "ForeName": "Elizabeth A",
        "Initials": "EA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Turner",
        "ForeName": "Mitchell L",
        "Initials": "ML"
      },
      {
        "Identifier": [
          "0000-0003-2251-2309"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Merino",
        "ForeName": "Vanessa F",
        "Initials": "VF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Yan",
        "ForeName": "Yu",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Kim",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0001-9606-5594"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Davis",
        "ForeName": "Stephanie L",
        "Initials": "SL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Komm",
        "ForeName": "Oliver",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Powell",
        "ForeName": "Jonathan D",
        "Initials": "JD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pulmonology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "D'Alessio",
        "ForeName": "Franco R",
        "Initials": "FR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Yolken",
        "ForeName": "Robert H",
        "Initials": "RH"
      },
      {
        "Identifier": [
          "0000-0001-9620-7070"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
          }
        ],
        "LastName": "Jain",
        "ForeName": "Sanjay K",
        "Initials": "SK"
      },
      {
        "Identifier": [
          "0000-0001-9902-6902"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lbrando@jhmi.edu."
          }
        ],
        "LastName": "Jones-Brando",
        "ForeName": "Lorraine",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI153349",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21AI149760",
        "Agency": "U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)",
        "Country": ""
      },
      {
        "GrantID": "R01AI153349",
        "Agency": "U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)",
        "Country": ""
      },
      {
        "GrantID": "R01AI145435A1",
        "Agency": "U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)",
        "Country": ""
      },
      {
        "GrantID": "Center for Infection and Inflammation Imaging Research",
        "Agency": "Johns Hopkins | School of Medicine, Johns Hopkins University (SOM, JHU)",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Commun Biol",
    "NlmUniqueID": "101719179",
    "ISSNLinking": "2399-3642"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cytokines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Isothiocyanates"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Sulfoxides"
    },
    {
      "RegistryNumber": "3QKI37EEHE",
      "NameOfSubstance": "remdesivir"
    },
    {
      "RegistryNumber": "415SHH325A",
      "NameOfSubstance": "Adenosine Monophosphate"
    },
    {
      "RegistryNumber": "GA49J4310U",
      "NameOfSubstance": "sulforaphane"
    },
    {
      "RegistryNumber": "OF5P57N2ZX",
      "NameOfSubstance": "Alanine"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "bioRxiv. 2021 Mar 25;:",
      "PMID": "33791708"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Adenosine Monophosphate"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Alanine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Caco-2 Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chlorocebus aethiops"
    },
    {
      "QualifierName": [
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "drug therapy",
        "immunology",
        "virology"
      ],
      "DescriptorName": "Coronavirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Coronavirus OC43, Human"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Cytokines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Synergism"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Isothiocyanates"
    },
    {
      "QualifierName": [
        "immunology",
        "virology"
      ],
      "DescriptorName": "Lung"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Macrophages, Alveolar"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Transgenic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Spleen"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Sulfoxides"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "T-Lymphocytes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vero Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "L.J.-B., A.A.O., R.H.Y., and S.K.J. are co-inventors on pending patent application USPA #63/142,598, \u201cMethods for inhibiting coronaviruses using sulforaphane\u201d filed by Johns Hopkins University. All other authors declare no competing interests."
}